deferoxamine has been researched along with Brain Infarction in 5 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Kooij, MA | 1 |
| Groenendaal, F | 1 |
| Kavelaars, A | 1 |
| Heijnen, CJ | 1 |
| van Bel, F | 1 |
| Warkentin, LM | 1 |
| Auriat, AM | 1 |
| Wowk, S | 1 |
| Colbourne, F | 1 |
| Hatakeyama, T | 1 |
| Okauchi, M | 1 |
| Hua, Y | 1 |
| Keep, RF | 1 |
| Xi, G | 1 |
| Pichiule, P | 1 |
| Chavez, JC | 1 |
| Schmidt, AM | 1 |
| Vannucci, SJ | 1 |
| Chu, K | 1 |
| Jung, KH | 1 |
| Kim, SJ | 1 |
| Lee, ST | 1 |
| Kim, J | 1 |
| Park, HK | 1 |
| Song, EC | 1 |
| Kim, SU | 1 |
| Kim, M | 1 |
| Lee, SK | 1 |
| Roh, JK | 1 |
5 other studies available for deferoxamine and Brain Infarction
| Article | Year |
|---|---|
Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat?
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Brain Infarction; Caspase 3; Cere | 2009 |
Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats.
Topics: Animals; Behavior, Animal; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Chelating Agents; Col | 2010 |
Deferoxamine reduces cavity size in the brain after intracerebral hemorrhage in aged rats.
Topics: Aging; Animals; Antigens, Differentiation; Behavior, Animal; Brain Infarction; Cell Count; Cerebral | 2011 |
Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia.
Topics: Animals; Brain Infarction; Cell Death; Cell Hypoxia; Deferoxamine; Female; Hypoxia-Inducible Factor | 2007 |
Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Chemokine CXCL12; Cyclooxygenase 2; Deferoxamine; | 2008 |